Back to Journals » Cancer Management and Research
Cancer Management and Research
Editor-in-Chief: Professor Yong Teng
Cancer Management and Research is part of our Elevate Series. This means that you will receive a concierge-level publishing experience, including dedicated support from our expert in-house Editorial team.
An international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (5189)
- Volume 18, 2026 (155)
- Volume 17, 2025 (276)
- Volume 16, 2024 (164)
- Volume 15, 2023 (153)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Latest articles:
- 5 records -
Inflammatory, Immune-Metabolic, and Vascular Biomarker Trajectories Across Treatment Modalities and Associations with Treatment-Related Complications in Oral Squamous Cell Carcinoma: A Prospective Study in Taiwan
Chou YF, Huang CH, Chen PR, You SJ
Cancer Management and Research 2026, 18:599334
Published Date: 8 July 2026
Systemic Inflammation Response Index, Albumin, and Hemoglobin-Albumin-Lymphocyte-Platelet Score for Stage-Stratified Esophageal Cancer Discrimination: A Retrospective Case-Control Study
Li Y, Cui Y, Liu M, Zhang J, Liu Y
Cancer Management and Research 2026, 18:614276
Published Date: 8 July 2026
Hippo-YAP/TAZ Signaling in Hematological Malignancies: Molecular Mechanisms, Pathway Crosstalk and Therapeutic Potential
Jiang W, Zhu C, Xu L, Ma N
Cancer Management and Research 2026, 18:618762
Published Date: 7 July 2026
The Interaction of PI3K/AKT/mTOR Pathway with the Tumor Microenvironment: A Dual Engine Driving Breast Cancer Progression and Reshaping Treatment Strategies
Huang X, Xia C, Jin X, Wang Y
Cancer Management and Research 2026, 18:616696
Published Date: 30 June 2026
Research Progress of HER2 in Cervical Carcinoma
Yang X, Tang Y, Liu G, Hui H, Guo L, Li N, Zhou Y
Cancer Management and Research 2026, 18:613300
Published Date: 26 June 2026
